Best practice portal main page

Opioid substitution treatment (OST) to prevent HIV and HCV in prison

Summary of the evidence

Rating: 
  • Unknown effectiveness

Opioid substitution treatment (OST) implemented in prison was found in a systematic review (Palmateer et al., 2022, 27 systematic review, 61 studies) to have insufficient evidence to either support or discount the intervention in:

  • preventing HIV transmission among PWID in prison
  • preventing HCV transmission among PWID in prison

Details

Note: this evidence summary is only valid for the outcomes, target groups, settings and substances/patterns of use described below.

Name of response option
  • Pharmacological treatment
Desired outcome(s)
  • reduce infectious diseases
Area(s)
  • Harm reduction
Specific substance or pattern of use
  • opioids
Target group(s) or setting(s)
  • prison

References

Explore all resources in the Best practice portal

 

Miniguides

A one-stop-shop for anyone planning or delivering health and social responses.

 

Implementation

Implementation inventories including Xchange, Healthy Nightlife Toolbox, EUPC and EIB

 

Evidence

All of the latest research and evidence on drug-related interventions.

 

Standards

Standards and guidelines for drug-related interventions, aimed at improving their quality.

Collaborations and partnerships in best practice

Logo of the Cochrane Collaboration
Logo of the Campbell Collaboration
Grade logo
WHO logo

About the Best practice portal

Top